Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

DBV Technologies S.A. (DBVT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

DBV Technologies S.A. (DBVT), most recent 12 months reported: revenue $5.02M, net loss $175.99M, free cash flow -$170.61M. Latest balance sheet on file: liquid cash $194.17M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): ZEO SCIENTIFIX, INC · FATE THERAPEUTICS INC · CG Oncology, Inc. · Taysha Gene Therapies, Inc. · Prime Medicine, Inc. · OCUGEN, INC. · CURIS, INC. · DYADIC INTERNATIONAL INC

Stock screener

Watchlist